["{\"step_by_step_thinking\": \"The provided documents describe multiple clinical trials. The first document is a multicenter clinical trial of epoetin beta for anemia of end-stage renal disease. It does not mention optic neuritis or its treatment. The second document is about setting up an 'EPO' system, which is not relevant to the question. The third document describes blood pressure in hemodialysis patients during amelioration of anemia with epoetin beta. Again, it does not mention optic neuritis. The fourth document discusses the evaluation of treatment by Cronassial for neuropathies and atrophy of the optic nerve, but it is a different study altogether. Finally, the fifth document describes long-term transfer-factor treatment for multiple sclerosis. None of these documents provide information about erythropoietin's effectiveness in treating optic neuritis.\", \"answer_choice\": \"B\"}"]